MPM BioVentures 2014, L.P.
SEC Form 4 insider trading activity
MPM BioVentures 2014, L.P. has filed 13 SEC Form 4 filings (40 transaction rows) across 2 companies, including TRDA, HOWL, with disclosures dating back to 2025. 13 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.
On the most recent filing, MPM BioVentures 2014, L.P. is listed as 10% Owner at Entrada Therapeutics, Inc. Inside the rolling window, MPM BioVentures 2014, L.P. reported no open-market purchases and 40 open-market sales totaling $5.8M in TRDA and HOWL. The largest disclosed transaction in the window is a sale of 192,500 TRDA shares on Sep 8, 2026, worth $1.4M.
Companies traded
Other insiders at TRDA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.8M
reported sales (SEC code S)
Companies
2
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| TRDA | 10% Owner | Sale | 38,500 | $274K | Sep 9 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 192,500 | $1.4M | Sep 9 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 28,837 | $206K | Sep 9 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 29,088 | $205K | Sep 3 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 25,131 | $181K | Sep 3 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 32,263 | $231K | Sep 3 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 38,922 | $280K | Aug 31 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 3,733 | $26K | Aug 31 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 44,259 | $309K | Aug 31 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 21,623 | $159K | Aug 27 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 26,522 | $200K | Aug 27 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 14,569 | $103K | Aug 27 | SEC ↗ | |
| HOWL | Former 10% Owner | Sale | 59,277 | $53K | Dec 4 | SEC ↗ | |
| HOWL | Former 10% Owner | Sale | 57,225 | $50K | Dec 4 | SEC ↗ | |
| HOWL | Former 10% Owner | Sale | 83,230 | $81K | Dec 4 | SEC ↗ | |
| HOWL | 10% Owner | Sale | 60,733 | $60K | Dec 1 | SEC ↗ | |
| HOWL | 10% Owner | Sale | 20,277 | $20K | Dec 1 | SEC ↗ | |
| HOWL | 10% Owner | Sale | 60,917 | $57K | Dec 1 | SEC ↗ | |
| HOWL | 10% Owner | Sale | 64,331 | $53K | Nov 25 | SEC ↗ | |
| HOWL | 10% Owner | Sale | 88,802 | $87K | Nov 25 | SEC ↗ | |
| HOWL | 10% Owner | Sale | 42,533 | $39K | Nov 25 | SEC ↗ | |
| HOWL | 10% Owner | Sale | 52,627 | $49K | Nov 20 | SEC ↗ | |
| HOWL | 10% Owner | Sale | 66,324 | $62K | Nov 20 | SEC ↗ | |
| HOWL | 10% Owner | Sale | 41,152 | $37K | Nov 20 | SEC ↗ | |
| HOWL | 10% Owner | Sale | 90,951 | $89K | Nov 17 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has MPM BioVentures 2014, L.P. made?
MPM BioVentures 2014, L.P. has filed 13 SEC Form 4 filings (40 transaction rows) across 2 companies, including TRDA, HOWL since 2025.
Which companies does MPM BioVentures 2014, L.P. trade?
MPM BioVentures 2014, L.P. has filed SEC Form 4 disclosures for 2 companies, including TRDA, HOWL.
When was MPM BioVentures 2014, L.P.'s most recent SEC Form 4 filing?
MPM BioVentures 2014, L.P.'s most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.
What is MPM BioVentures 2014, L.P.'s total buy and sell value in the current window?
Inside the rolling retention window, MPM BioVentures 2014, L.P. bought $0 and sold $5.8M based on SEC Form 4 filings.
What was MPM BioVentures 2014, L.P.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 192,500 TRDA shares on 2026-09-08, worth $1.4M, per SEC Form 4 filings.